common.study.topics.clinical

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

common.study.values.description

“ASA in Prevention of Ovarian Cancer (STICs and STONEs)”

While ASA is not a cancer medication, research suggests that taking ASA reduces the probability of getting many types of cancer because of its anti-inflammatory action. Inflammation in the ovaries during ovulation is thought to contribute to the development of ovarian cancer, and, because ASA is an anti-inflammatory medication, it may help to prevent it.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Acetylsalicylic acid

81 mg PO daily or 325 mg PO daily

Placebo

One tablet PO daily

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Randomized Phase II Double-Blind Placebo-Controlled Trial of Acetylsalicylic Acid (ASA) in Prevention of Ovarian Cancer in Women With BRCA 1/2 Mutations (STICs and STONEs)

common.study.values.clinical-trial-id

NCT03480776

participant.views.study.view.id

ZdP06d